Vemurafenib sensitivity skin reaction after ipilimumab

N Engl J Med. 2012 Mar 1;366(9):866-8. doi: 10.1056/NEJMc1114329.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antibodies, Monoclonal / adverse effects*
  • Antineoplastic Agents / adverse effects*
  • Drug Eruptions / etiology*
  • Drug Eruptions / pathology
  • Exanthema / chemically induced
  • Humans
  • Indoles / adverse effects*
  • Ipilimumab
  • Melanoma / drug therapy
  • Melanoma / genetics
  • Melanoma / secondary
  • Middle Aged
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / genetics
  • Skin Neoplasms / pathology
  • Sulfonamides / adverse effects*
  • Vemurafenib

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Indoles
  • Ipilimumab
  • Sulfonamides
  • Vemurafenib